These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 15940128

  • 1. Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature.
    Kocabas CN, Yavuz AS, Lipsky PE, Metcalfe DD, Akin C.
    J Allergy Clin Immunol; 2005 Jun; 115(6):1155-61. PubMed ID: 15940128
    [Abstract] [Full Text] [Related]

  • 2. Mastocytosis.
    Metcalfe DD.
    Novartis Found Symp; 2005 Jun; 271():232-42; discussion 242-9. PubMed ID: 16605139
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis.
    Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB, Mastocytosis Centre Odense University Hospital (MastOUH).
    Eur J Haematol; 2012 Jul; 89(1):42-6. PubMed ID: 22469616
    [Abstract] [Full Text] [Related]

  • 5. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
    Sotlar K, Colak S, Bache A, Berezowska S, Krokowski M, Bültmann B, Valent P, Horny HP.
    J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
    [Abstract] [Full Text] [Related]

  • 6. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.
    Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I.
    Nat Genet; 1996 Mar; 12(3):312-4. PubMed ID: 8589724
    [Abstract] [Full Text] [Related]

  • 7. KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.
    McClintock-Treep SA, Horny HP, Sotlar K, Foucar MK, Reichard KK.
    J Clin Pathol; 2009 Dec; 62(12):1147-9. PubMed ID: 19729359
    [Abstract] [Full Text] [Related]

  • 8. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
    Wimazal F, Walchshofer S, Baghestanian M, Chott A, Sperr WR, Kopp C, Sillaber C, Semper H, Horny HP, Tröndle U, Födinger M, Schwarzinger I, Lechner K, Valent P.
    Wien Klin Wochenschr; 1998 Feb 13; 110(3):79-88. PubMed ID: 9553202
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A, Garcia-Montero AC, Sanchez L, Escribano L, REMA.
    Br J Haematol; 2007 Jul 13; 138(1):12-30. PubMed ID: 17555444
    [Abstract] [Full Text] [Related]

  • 13. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophil/mast cell precursors from chronic myelogenous leukaemia.
    Fukuda T, Kamishima T, Tsuura Y, Suzuki T, Kakihara T, Naito M, Kishi K, Matsumoto K, Shibata A, Seito T.
    J Pathol; 1995 Oct 13; 177(2):139-46. PubMed ID: 7490680
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.
    Akin C, Kirshenbaum AS, Semere T, Worobec AS, Scott LM, Metcalfe DD.
    Exp Hematol; 2000 Feb 13; 28(2):140-7. PubMed ID: 10706069
    [Abstract] [Full Text] [Related]

  • 15. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.
    Pedersen M, Rönnstrand L, Sun J.
    Cell Signal; 2009 Mar 13; 21(3):413-8. PubMed ID: 19049823
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis, progression patterns and prognostication in mastocytosis.
    Sperr WR, Valent P.
    Expert Rev Hematol; 2012 Jun 13; 5(3):261-74. PubMed ID: 22780207
    [Abstract] [Full Text] [Related]

  • 17. KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis.
    Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB.
    Dermatology; 2013 Jun 13; 226(3):233-7. PubMed ID: 23774045
    [Abstract] [Full Text] [Related]

  • 18. Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma.
    Kim Y, Weiss LM, Chen YY, Pullarkat V.
    Leuk Res; 2007 Dec 13; 31(12):1749-54. PubMed ID: 17544505
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
    Sotlar K.
    Verh Dtsch Ges Pathol; 2007 Dec 13; 91():169-76. PubMed ID: 18314612
    [Abstract] [Full Text] [Related]

  • 20. Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.
    Jara-Acevedo M, Teodosio C, Sanchez-Muñoz L, Álvarez-Twose I, Mayado A, Caldas C, Matito A, Morgado JM, Muñoz-González JI, Escribano L, Garcia-Montero AC, Orfao A.
    Mod Pathol; 2015 Aug 13; 28(8):1138-49. PubMed ID: 26067933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.